Mechanisms of Antiparkinsonian Anticholinergic Therapy Revisited

This publication has 228 references indexed in Scilit:

• A Role for Dopamine-Mediated Learning in the Pathophysiology and Treatment of Parkinson’s Disease
  Cell Reports, 2012
• Effects of dopamine depletion on LFP oscillations in striatum are task- and learning-dependent and selectively reversed by l -DOPA
  Proceedings of the National Academy of Sciences, 2012
• Beta band stability over time correlates with Parkinsonian rigidity and bradykinesia
  Experimental Neurology, 2012
• Roles of the M1 Muscarinic Acetylcholine Receptor Subtype in the Regulation of Basal Ganglia Function and Implications for the Treatment of Parkinson’s Disease
  The Journal of Pharmacology and Experimental Therapeutics, 2012
• The History of Parkinson's Disease: Early Clinical Descriptions and Neurological Therapies
  Cold Spring Harbor Perspectives in Medicine, 2011
• Enhanced striatal cholinergic neuronal activity mediatesl-DOPA–induced dyskinesia in parkinsonian mice
  Proceedings of the National Academy of Sciences, 2010
• Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry
  Nature, 2010
• Presynaptic dopaminergic compartment determines the susceptibility to L-DOPA–induced dyskinesia in rats
  Proceedings of the National Academy of Sciences, 2010
• Maladaptive striatal plasticity in l-DOPA-induced dyskinesia
  2010
• Dichotomous Dopaminergic Control of Striatal Synaptic Plasticity
  Science, 2008